drugset / Trial / NCT00856258

Multiple Dose Study in Healthy Volunteers to Assess Safety, Pharmacokinetics and Pharmacodynamics of PF 03882845

NCT00856258

Phase 1 Terminated 10 enrolled Pfizer
RandomizedSingle-groupDouble-blind

Summary

To demonstrate the safety, pharmacokinetics and pharmacodynamics of drug candidate.

Timeline

Start
2009-03
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator PF-03882845 Small molecule Oral

Indications

No indication recorded.